Stelios Andreadis is the SUNY Distinguished Professor of Chemical and Biological Engineering, Biomedical Engineering at the University at Buffalo, State University of New York. He is also the Director of the Cell, Gene and Tissue Engineering Center and served as the Director of the Stem Cells in Regenerative Medicine (SCiRM) Training Program. His research interests span a wide spectrum from fundamental to technological to pre-clinical/translational research.

He co-founded Angiograft, to commercialize the cell-free vascular grafts that were developed in his laboratory as arterial replacement grafts for treatment of cardiovascular disease.

Andreadis received his MS in Applied Mathematics and PhD degree in Chemical Engineering from the University of Michigan. He completed postdoctoral training at the Center for Engineering in Medicine at Harvard Medical School.